Skip to main content
Fig. 2 | Journal of Nanobiotechnology

Fig. 2

From: Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targeting moiety and diagnostic tool for pancreatic cancer

Fig. 2

IHC confirms overexpression of galectins (Gal-1, -3, -4) in pancreatic tumors. a Human pancreatic ductal adenocarcinoma (Hu PDAC); b Murine (Mu) orthotopic (ot) and subcutaneous (s.c.) tumors of Panc-1 and c orthotopic and subcutaneous Su.86.86 tumors of nude mice. Some representative galectin-1, -3, -4 stained areas (cytosolic, membraneous and stroma) are indicated by arrows

Back to article page